Brigitte M. Ronnett - Concepedia

Author

Brigitte M. Ronnett

Also Known As

B M Ronnett, B Ronnett, B. M. Ronnett, B. Ronnett, B.M. Ronnett, Brigitte (Biggy) Ronnett, Brigitte M Ronnett, Brigitte M. Ronnett, Brigitte Ronnett, Hendricks, William P.D.

245

Publications

18.8K

Citations

H-Index

130

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Johns Hopkins Hospital MedStar Washington Hospital Center University of Maryland, Baltimore

About

Brigitte M. Ronnett is an author at Johns Hopkins University specializing in medicine, pathology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	80	11.5K
2	Public Health	16	17	2.3K
3	Cell Biology	7	7	509
4	Engineering	1	1	35
5	Health Sciences	1	1	219

Brigitte M. Ronnett

121

Publications

15.4K

Citations

H-Index

Page 1

	Year	Citations
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta, The Lancet Oncology VaccinationVaccinologyVaccine DevelopmentCervical CancerHuman Papillomavirus Vaccines	2005	1.6K
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology Teresa M. Darragh, Terence J. Colgan, J. Thomas Cox, Archives of Pathology & Laboratory Medicine GynecologyPathologyCytopathologyGynecology OncologyCervical Pathology	2012	977
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin Jeffrey D. Seidman, Iren Horkayne‐Szakaly, Moutaz Haiba, International Journal of Gynecological Pathology Tumoral PathologyGynecological SurgeryStage DistributionMedicineHistopathology	2003	556
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18 Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano, Vaccine VaccinationVaccine DevelopmentHuman Papillomavirus VaccinesVaccine TargetImmunology	2006	465
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial Warner K. Huh, Elmar A. Joura, Anna R. Giuliano, The Lancet VaccinationVaccine SafetyVaccinologySafety AnalysesHuman Papillomavirus Vaccines	2017	448
Primary and Metastatic Mucinous Adenocarcinomas in the Ovaries Jeffrey D. Seidman, Robert J. Kurman, Brigitte M. Ronnett The American Journal of Surgical Pathology Tumoral PathologyGynecological SurgeryEndocrine-related CancerMucinous CarcinomasMedicine	2003	427
Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin? Christopher G. Przybycin, Robert J. Kurman, Brigitte M. Ronnett, The American Journal of Surgical Pathology Tumoral PathologyGynecological SurgeryInvasive CarcinomaMedicineFallopian Tube Origin	2010	407
Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis Alan K. Meeker, Jessica Hicks, Christine A. Iacobuzio–Donahue, Clinical Cancer Research	2004	307
Pseudomyxoma peritonei in women: A clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential Brigitte M. Ronnett, Robert J. Kurman, Christopher M. Zahn, Human Pathology	1995	278
Absolute Risk of Endometrial Carcinoma During 20-Year Follow-Up Among Women With Endometrial Hyperplasia James V. Lacey, Mark E. Sherman, Brenda B. Rush, Journal of Clinical Oncology PrognosisEpidemiology Of CancerGynecologyMenstrual CycleEndometrial Carcinoma	2010	266

Page 1